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Available online 19 August 2019Background: Individuals born with low birth weight (LBW) have an increased risk of metabolic diseases when
exposed to diets rich in calories and fat but may respond to fasting in a metabolically preferential manner. We
hypothesized that impaired foetal growth is associatedwith differential regulation of gene expression and epige-
netics in metabolic tissues in response to fasting in young adulthood.
Methods: Genome-wide expression and DNA methylation were analysed in subcutaneous adipose tissue (SAT)
and skeletalmuscle from LBWand normal birthweight (NBW)men after 36 h fasting and after an isocaloric con-
trol study using microarrays.
Findings: Transcriptome analyses revealed that expression of genes involved in oxidative phosphorylation
(OXPHOS) and other key metabolic pathways were lower in SAT from LBW vs NBW men after the control
study, but paradoxically higher in LBW vs NBWmen after 36 h fasting. Thus, fasting was associated with down-
regulated OXPHOS andmetabolic gene sets inNBWmen only. Likewise, in skeletalmuscle onlyNBWmen down-
regulated OXPHOS genes with fasting. Few epigenetic changes were observed in SAT and muscle between the
groups.
Interpretation: Our results provide insights into the molecular mechanisms in muscle and adipose tissue
governing a differential metabolic response in subjects with impaired foetal growth when exposed to fasting
in adulthood. The results support the concept of developmental programming of metabolic diseases including
type 2 diabetes.
Fund: The Swedish Research Council, the Danish Council for Strategic Research, the NovoNordisk foundation, the
Swedish Foundation for Strategic Research, The European Foundation for the Study of Diabetes, The EU 6th
Framework EXGENESIS grant and Rigshospitalet.
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Type 2 diabetes1. Introduction
Individuals bornwith low birthweight (LBW) have increased risk of
obesity [1] and type 2 diabetes (T2D) [2,3] later in life. Young adults
born with LBW exhibit increased abdominal fat mass [4], increased
whole body lipolysis [5], and reduced expression of key insulin signal-
ling proteins in subcutaneous adipose tissue (SAT) and skeletal musclendocrinology, Rigshospitalet,
mark
s Unit, Department of Clinical
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erg), charlotte.ling@med.lu.se
. This is an open access article under[6,7]. These changes may all contribute to the increased risk of T2D in
LBW individuals, especially if subjected to diets rich in calories and fat.
Accordingly, we have shown that LBW subjects exposed to a 5-day
high-fat overfeeding challenge were more prone to develop peripheral
insulin resistance than normal birth weight (NBW) controls [8]. Fur-
thermore, appetite regulating hormones including leptin and PYY
were lower in LBW compared with NBW subjects after overfeeding
[8,9].
Caloric restriction, including fasting, has been associated with im-
proved health and survival in several animal and human studies [10].
Nevertheless, there is limited knowledge of whether people respond
to fasting in a differentialmanner, and the extent towhich thismight in-
fluence their risk of cardiovascular and metabolic diseases. In a recent
study we showed that healthy young men born with LBW have athe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Research in context
Evidence before this study
Caloric restriction, including fasting, has been associated with im-
proved survival and health in several animal and human studies.
However, the molecular mechanisms contributing to this remains
to be dissected in humans. Additionally, individuals born with a
low birth weight (LBW) have an increased risk of obesity, diabetes
and cardiovascular disease when exposed to diets rich in calories
and fat and they may benefit from fasting. In 2015, we showed
that healthy young men born with LBW have a more energy con-
serving phenotype after 36 h of fasting than matched normal
birth weight (NBW) control subjects, including lower energy ex-
penditure, lower fat oxidation and lower triglyceride levels. To
clarify whether LBW individuals have a different molecular re-
sponse to fasting than NBW individuals, we carried out a study
of genome-wide transcription and DNA methylation in human ad-
ipose tissue and skeletal muscle from 37 young healthy men born
with LBWor NBWafter 36 h of fasting and after an isocaloric con-
trol diet.
Added value of this study
This study provides the first molecular evidence that fasting is as-
sociated with a downregulation of oxidative phosphorylation
(OXPHOS) and metabolic gene sets in NBW men, whereas LBW
men displayed unchanged levels ofmetabolic gene sets in adipose
tissue with fasting. Moreover, we found that expression of genes
involved in OXPHOS and key metabolic pathways were lower in
adipose tissue, and partly also in muscle, from LBW vs NBW
men after control conditions, but paradoxically higher in LBW vs
NBW men after 36 h fasting. The lower expression of OXPHOS
and other key metabolic gene sets in adipose tissue during isoca-
loric control conditions was further validated in an independent
cohort of LBW and NBW individuals. DNA methylation alterations
could not explain the differences in mRNA response to fasting be-
tween the LBW vs NBWmen in the current study.
Implications of all the available evidence
This study provides novel human transcriptomic and epigenetic
data from human adipose tissue and muscle after prolonged
fasting. Our results support an impact of foetal growth on the reg-
ulation of the transcriptional response to fasting in adulthood,
which may contribute to the predisposition of metabolic diseases
in LBW individuals. Overall, our data explain why some people
may benefit from fasting with an improved metabolic phenotype
while other will not.
342 L. Gillberg et al. / EBioMedicine 47 (2019) 341–351more energy conserving phenotype after 36 h of fasting than matched
NBW control subjects, including lower energy expenditure, lower fat
oxidation, and lower insulin and triglyceride levels [11]. These data
strongly support the so called ‘thrifty phenotype hypothesis’ and the
assumption that LBW individuals in adulthood may have an improved
tolerance to - or cope better with - fasting/energy restriction that was
shaped in utero. Some studies suggest that the adult ‘memory’ of an ad-
verse foetal development can be directed to epigenetic modifications
e.g. DNA methylation and less epigenetic changes took place in muscle
of LBW versus NBW men when exposed to a short-term high-fat diet
[11–15]. In another study, we found reduced epigenetic flexibility in
adipose tissue from LBW subjects in the genes encoding leptin and
adiponectin in response to fasting [16]. However, the molecularalterations that cause insulin resistance in adipose tissue and skeletal
muscle from LBW individuals are still not well documented.
We hypothesized that fasting might unmask transcriptional and/or
epigenetic alterations in insulin sensitive tissues from healthy individ-
uals who were born with LBW. Such transcriptional and epigenetic
differences may contribute to metabolic differences seen in LBW vs
NBW subjects and predispose to T2D and obesity. To address these
questions, we applied an unbiased array approach to determine
genome-wide gene expression and DNAmethylation patterns in subcu-
taneous adipose tissue (SAT) and skeletal muscle from healthy young
men born with LBW and matched NBW controls after 36 h fasting and
after a control study (12 h overnight fasting). We first tested whether
there are differences between the birth weight groups, both after 36 h
fasting and after the control study. Secondly, we analysed differences
between the fasting intervention and the control study in both birth
weight groups separately. We performed these analyses for physiologi-
cal parameters as well as for gene expression and DNA methylation in
SAT and skeletal muscle.
2. Materials and methods
2.1. Study design
Healthy, young (22–27 years) Danish men born at term (week
39–41) were recruited from the Danish National Birth Register [11].
SAT and skeletal muscle biopsies were excised from 37 men, whereof
20 born with a LBW (lowest 10th percentile) and 17 age- and BMI-
matched controls born with a NBW (50th–75th percentile) (Table S1).
Exclusion criteria were diabetes in the family in two generations, phys-
ical exercise N 10 h/week, BMI N 30 kg/m2 or use of medication known
to affect metabolism [11].
All participants were subjected to 36 h of fasting (fasting study), and
after 2–4 months, 8 of the LBW and 8 of the NBWmen participated in
a control study where the subjects received standardized meals and
biopsies were excised after an overnight (12 h) fast [16] (Fig. 1).
One LBW and two NBW men did only participate in the collection of
overnight fasting samples and biopsy excision after 3 days of standard-
ization by control diet and they did not participate in further clinical
examinations during the control study [16]. Three days prior to the
fasting and control studies, all participants received standardized, pre-
cooked meals with fixed calories (10 MJ/day) containing 35% fat, 15%
protein and 50% carbohydrate, and abstained from exercise, alcohol
and soft drinks [11]. The participants received a standardized meal at
7:30 p.m. after arriving at the laboratory and fasted thereafter. They
were instructed to go to sleep at 10:00 p.m. Water ad libitum was
allowed, and smokers were allowed to use a 10 mg Nicorette® inhaler
(McNeil). Individuals spent two 10-min sessions on an ergometer bicy-
cle during the first day to avoid inactivity. On the first day of the control
study, participants received standardized meals at 8:00 (breakfast),
12:00 (lunch), 15:00 (snack) and 19:30 (dinner) (Fig. 1). On the second
day between 7:00 and 7:30, after 36 h (fasting study) and 12 h (control
study) fasting respectively, abdominal SAT and skeletal muscle (vastus
lateralis) biopsies were excised. Short after, a 180-min intravenous glu-
cose tolerance test (IVGTT)was initiated.Written informed consentwas
obtained before the study from all participants. The local ethics commit-
tee approved the study (HD-2008-127) and the protocol was in accor-
dance with the Helsinki II declaration.
2.2. Clinical examinations
The fasting study and the control study were carried out with iden-
tical study settings, apart from one LBW and two NBWmen of the con-
trol study who, after 3 days of standardized meals, only participated in
the collection of tissue biopsies and blood samples after an overnight
fasting. Clinical examinations of this study have been described in detail
previously [11,16]. Anthropometric measurements were determined
Sleep
19:30       22:00 8:00         12:00                   19:30 07:30  08:00
Fasting
20 LBW and 17 NBW
Control study
8 LBW and 8 NBW
12h Fasting
Biopsies
Sleep
IVGTT
DXA scan
36h Fasting
Fig. 1. Study design. The fasting study (36 h fasting; 20 LBW and 17 NBW) and the control study (standardized meals followed by 12 h overnight fasting; 8 LBW and 8 NBWmen) was
separated by a period of 2–4 months. The time indicates when different interventions (sleep, meals, biopsy excision and IVGTT) were performed during the first, second and third day
of the study regimen. The grey coloured plate, knife and fork images represent the standardized meals in the control study. IVGTT, intravenous glucose tolerance test; LBW, low birth
weight; NBW, normal birth weight.
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antecubital vein at 08:00 and 14:00 the first day, and hourly from
20:00 until 7:59 the following morning to sample for glucose, insulin
and non-esterified fatty acids. Tissue biopsies were excised under local
anaesthesia with Xylocain (AstraZeneca, Cambridge, UK) using a
Bergström needle with suction, snap frozen in liquid nitrogen and
stored at −80 °C. Energy expenditure (EE) and substrate oxidation
rates were examined with indirect calorimetry for 30 min at baseline
(control study) and after 31 h and 34 h of fasting (fasting study;
Deltatrac monitor, Datex instruments). The respiratory quotient (RQ)
was calculated as CO2 expired/O2 consumed, and net lipid and glucose
oxidation rates were calculated using the non-protein RQ [17].
2.3. Genome-wide gene expression analyses in SAT and skeletal muscle
Total RNAwas extracted from 52 SAT biopsies (20 LBW and 16 NBW
after fasting, 8 LBW and 8 NBW after control study) using themiRNeasy
Kit (Qiagen, Hilden, Germany) and subsequently purified from small
RNA molecules with the RNeasy MinElute Cleanup Kit (Qiagen). Simi-
larly, RNA from 52 skeletal muscle biopsies (20 LBW and 16 NBW
after fasting, 8 LBW and 8 NBW after control study) was extracted
with TRI reagent (Sigma-Aldrich, St. Louis, MO, USA). RNA quality was
assessed with the Agilent 2100 Bioanalyzer system (Agilent Technolo-
gies, Basel, Switzerland). Genome-wide expression of 28,838 annotated
transcripts representing 18,229 unique genes was analysed in all RNA
samples using the GeneChip Human Gene 1.0 ST arrays (Affymetrix,
Santa Clara, CA, USA) following Affymetrix standard protocol.
2.4. Genome-wide DNA methylation analyses in SAT and skeletal muscle
DNA extracted from 51 SAT biopsies (19 LBW and 16 NBW after
fasting, 8 LBW and 8 NBW after control study) with the QIAamp DNA
Mini Kit (Qiagen) and 50 skeletal muscle biopsies (18 LBW and 16
NBW after fasting, 8 LBW and 8 NBW after control study) with the
DNeasy Kit (Qiagen) was used for DNA methylation analysis using
Infinium HumanMethylation450 BeadChips (Illumina, San Diego, CA,
USA). Paired samples (control and fasting) were placed on the same
chip, and samples from LBW and NBW individuals were evenly
distributed.
2.5. Bioinformatics and statistical analysis
Gene expression data were background corrected and quantile nor-
malized with robust multi-array average (RMA) using Bioconductor
[18,19]. Subsequently, the array data was analysed with unpaired
(LBW vs NBW) and paired (fasting vs control) Student's t-tests in R
(www.r-project.org). Gene expression analyses in SAT were performed
in all 37 individuals, but one NBW participant was only analysed at the
control study due to lack of SAT RNA after the fasting study. Thus, 7
NBW and 8 LBWmen were included in the paired analyses of the tran-
scriptional response to fasting in SAT. In skeletal muscle, thetranscriptional response to fasting vs control study was analysed in 8
NBW and 8 LBW men. We applied false discovery rate (FDR) analysis
to account for multiple testing, where FDR b 5% (q b 0.05) was consid-
ered significant.
For the DNA methylation data, methylation values were calculated
frommethylated and unmethylated allele intensity values and analysed
as previously described [20]. ComBatwas used for batch-correction [21]
and β-values from 0 to 1 (0–100%methylation)were used to report the
outcome. DNA methylation data was analysed with Wilcoxon tests
(fasting vs control study) and two-sample Mann–Whitney U tests
(LBW vs NBW). FDR corrections for DNA methylation were performed
on subsets of genes included in this study. All p- and q-values presented
are two-tailed.
2.6. GSEA pathway analysis
For the mRNA expression data, pathway analyses were performed
on curated gene sets of KEGG (Kyoto Encyklopedia of Genes and Ge-
nomes) using Gene Set Enrichment Analysis (GSEA; http://www.
broadinstitute.org/gsea/) [22,23]. For differences between LBW and
NBW men, unpaired t-tests were applied on expression values after
RMA normalization using Bioconductor [18,19]. For differences be-
tween fasting and control study, individual gene expression ratios and
paired t-tests were used to create a gene list where each transcript got
a rank based on the significance of the analysis. The GSEA analysis in-
cluded 186 gene sets (size 9–349 genes/gene set). Results were sorted
on normalized enrichments scores and q b 0·05 was considered signif-
icant based on FDR. Pathways related to human diseases are excluded in
figures and separated from the other pathways in tables due to their
overlap with enriched genes in other pathways (i.e. OXPHOS and
Parkinson's disease).
2.7. Validation cohort
In a previous study, 16 young healthy LBW men and 24 matched
NBW men were exposed to 5 days of high-fat overfeeding (HFO;
+50% calories, 60% of energy from fat) and an individualized weight-
maintaining 3-day control diet (35% of energy from fat) in a randomized
order separated by a washout period of 6–8 weeks [8]. Genome-wide
gene expression was analysed using GeneChip Human Gene 1.0 ST ar-
rays (Affymetrix) in SAT biopsies excised after an overnight fast [24].
Bioinformatics, t-tests and GSEA analyses were performed as in the
fasting study.
3. Results
3.1. Physiological differences between LBWandNBWmenaswell as in their
response to fasting
Physiological and metabolic differences between birthweight
groups, and their response to fasting, was studied in all participants
344 L. Gillberg et al. / EBioMedicine 47 (2019) 341–351after 36 h fasting (fasting study, 20 LBW and 17 NBW men) and for a
subset of the participants after an isocaloric diet followed by an over-
night (12 h) fast (control study, 8 LBW and 8 NBWmen) (Fig. 1). Their
clinical characteristics are presented in Table S1 and Table 1,
respectively.
First, we compared physiological differences after an overnight fast
between birth weight groups in all participants as well as in the sub-
group included in the control study. The LBW and NBW individuals
were matched for age and BMI, and there were no significant differ-
ences in their glucose, insulin or lipid profiles in neither all participants
(Table S1; 20 LBW vs 17 NBW) nor in the subgroup that only partici-
pated in the control study (Table 1; 8 LBW vs 8 NBW). Moreover, in
the control study, there were no significant differences in EE, RQ and
glucose/fat oxidation between the LBW and NBWmen, but EE and fat
oxidation (FOX) tended to be lower in the subgroups of LBW vs NBW
men (EE: 1411 vs 1562 kcal/24 h, p = 0.08; FOX: 30·2 vs
41.4 mg/min, p= 0·12; Table 1).
We then studied the physiological differences between birth weight
groups after 36 h fasting in the full cohort. Here, the LBWmen had sig-
nificantly lower EE (1633 vs 1768 kcal/24 h, p= 0·046), FOX (78·6 vs
91·4 mg/min, p = 0·02) and triglyceride levels (0·78 vs
0·95mmol l−1, p=0.02; Table S1) compared toNBWmen. Glucose ox-
idation and levels of FFA, plasma glucose and serum insulin in blood
were similar between groups after fasting.
Next, we investigated the physiological response to fasting by
comparing the subjects included in both the fasting and the control
study (Fig. 1). After fasting compared to after the control study,
plasma glucose and serum insulin levels dropped drastically and
the liver of both LBW and NBW men became more insulin sensitive
based on the HOMA-IR index (Table 1). The EE increased signifi-
cantly with fasting in the LBW men only (p = 0·02). The decrease
in glucose oxidation and increase in fat oxidation was significant
in both groups, reflected by a significantly lower RQ after fasting
(Table 1). Triglyceride levels dropped significantly in the LBW
men only, whereas FFA levels increased N3-fold in both groups (p
≤ 0·005).
Together, there are physiological differences between the birth
weight groups mainly seen after and in response to fasting.Table 1
Clinical characteristics of the LBW and NBW participants who were exposed to both 36 h fastin
Parameter LBW (n = 8)
Control study
Body composition
Weight (kg) 71.8 ± 9.1
BMI (kg/m2) 22.7 ± 2.7
Body fat (%) 15.4 ± 5.7
WHR 0.93 ± 0.04
Glucose and Insulin profile
Plasma glucose (mmol l/L) 4.9 ± 0.4
Serum insulin (pmol l−1) 23.8 ± 7.9
Insulin sensitivity
HOMA-IR 0.75 ± 0.28
Indirect calorimetry measurements
EE (kcal/24 h)a 1411 ± 83
RQa 0.86 ± 0.03
GOX (mg/min)a 116.7 ± 24.0
FOX (mg/min)a 30.2 ± 11.6
Lipid profile
FFA (μmol l−1)a 161 ± 54
Total cholesterol (mmol l−1) 4.4 ± 0.5
HDL cholesterol (mmol l−1) 1.27 ± 0.29
Triglycerides (mmol l−1) 1.04 ± 0.25
Data are mean ± SD. Clinical data was obtained 1 h after biopsy excision after both the 36 fast
were obtained after 34 h fasting. Significant differences for paired comparisons between 36 h fas
between LBW and NBWmen: #p ≤ .05.
a Data from7 of the LBWand 6 of theNBW individuals only. EE, energy expenditure; RQ, resp
minimal modelling. Clinical data from the fasting intervention has been published previously [3.2. Differences in expression of metabolic gene sets in SAT and skeletal
muscle in LBW compared with NBW subjects after control and fasting
studies
In the control study, gene expression in SAT and skeletal muscle was
investigated in 8 LBW and 8 NBW subjects. After fasting, RNA from SAT
and muscle was available for 20 LBW and 16 NBW subjects. We first
tested if sets of related genes (KEGGpathways) had different expression
in LBW versus NBWmen by performing GSEA [23].
3.2.1. SAT gene expression
After the control study, SAT displayed 27 significant gene sets with
lower expression in LBW vs NBW men (Fig. 2; Table S2, sheet A).
These include genes involved in oxidative phosphorylation (OXPHOS,
Fig. 3A and B) and multiple other central metabolic pathways in carbo-
hydrate, lipid and amino-acid metabolism. Remarkably and in contrast,
after fasting, expression of 17 gene sets including several of these met-
abolic pathways were paradoxically increased in SAT from LBW vs NBW
men (Fig. 2; Fig. 3A and B; Table S2, sheet B). Moreover, after the control
study, six pathways involved in processing of genetic information were
downregulated in SAT from LBW men (Fig. 2; Table S2, sheet A). We
then tested whether the expression of individual genes was different
in SAT of LBW vs NBW men after the control study and/or fasting.
Some genes showed nominal differences in expression (p b 0·05) be-
tween the groups but nonewere significant after correction formultiple
testing (data not shown).
3.2.2. Muscle gene expression
Similar to SAT, in the control study,we found lower expressionof genes
in the OXPHOS pathway in skeletal muscle from LBW vs NBWmen, to-
gether with a reduction of folate biosynthesis (Fig. 4; Table S2, sheet C).
In contrast, after fasting, muscle from LBW compared with NBW men
displayed no significant differences in OXPHOS expression (Fig. 3A and
C) and lower expression of three gene sets including the ribosome path-
way andECMreceptor interaction (Fig. 4; Table S2, sheetD). Some individ-
ual genes had nominal differences in expression (p b 0·05) in skeletal
muscle from LBW vs NBWmen after the control study and/or fasting but
these were not significantly different after correction for multiple testing.g and the control study (12 h overnight fast).
LBW (n = 8) NBW (n = 8) NBW (n = 8)
Fasting Control study Fasting
71.9 ± 9.6 80.3 ± 11.7 81.1 ± 11.6
22.7 ± 2.8 23.5 ± 4.0 23.7 ± 4.1
15.9 ± 5.9 16.2 ± 5.5 16.7 ± 5.4
0.90 ± 0.06 0.91 ± 0.05 0.90 ± 0.06
3.9 ± 0.3** 5.0 ± 0.3 3.9 ± 0.5**
12.2 ± 5.5* 21.1 ± 6.7 11.4 ± 3.1*
0.41 ± 0.17* 0.68 ± 0.23 0.38 ± 0.19*
1550 ± 137* 1562 ± 182 1642 ± 195
0.78 ± 0.02** 0.85 ± 0.02 0.76 ± 0.03*
61.0 ± 21.9** 123.9 ± 22.4 46.3 ± 28.0*
69.2 ± 16.7** 41.4 ± 10.8 86.6 ± 22.0*
582 ± 166** 173 ± 61 556 ± 213**
4.4 ± 0.4 4.3 ± 0.8 4.3 ± 0.9
1.27 ± 0.31 1.05 ± 0.13 1.06 ± 0.22
0.80 ± 0.17* 1.07 ± 0.34 1.01 ± 0.26 #
ing and the control study intervention except for indirect calorimetry measurements that
ting and control study: *p ≤ .05. **p ≤ .005. Significant differences for unpaired comparisons
iratory quotient; GOX, glucose oxidation; FOX, fat oxidation. HOMA-IRwas calculated from
11].
Fig. 2. Key metabolic gene sets are differentially regulated in subcutaneous adipose tissue after 36 h fasting vs control study (horizontally) and in LBW vs NBWmen (vertically). KEGG
Metabolism pathways are coloured by subgroup: Energy (dark blue), Carbohydrate (light blue), Lipid (red), Amino acid (purple), Other amino acids (purple), Nucleotide, Glycan
biosynthesis and Terpenoids and polyketides (grey). Also coloured: Immune system (Organismal system; orange). Human diseases pathways are not included in the figure. #Pathway
lower in LBW vs NBW after control study and higher in LBW vs NBW after fasting. xPathway regulated in the opposite direction in response to fasting in LBW and NBW men. SAT,
subcutaneous adipose tissue; LBW, low birth weight; NBW, normal birth weight.
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men are in line with what is seen in SAT and muscle from subjects
with T2D andmay predispose to diabetes [22,25]. ThemRNA expression
of individual OXPHOS genes were not statistically significant in LBW vs
NBWmen after correction for multiple testing, as described above.
3.3. Identification of transcription factor binding motifs of importance for
differential gene expression in LBW vs NBWmen
To identify transcription factors that may control the transcriptional
differences in SAT andmuscle between LBWandNBWsubjects, we used
PSCAN and JASPAR [26,27]. Here, we searched for overrepresentation of
specific transcription factor binding sequences among the genes con-
tributing to enrichment in significant GSEA pathways (Table S2, sheet
A–D). Recognition sequences for 3 transcription factors, including
KLF14, were significantly enriched in SAT based on enriched genes con-
tributing to the 20 most significant KEGG pathways with lower expres-
sion in LBW vs NBW men after the control study (Table S3, sheet A),
whereas the enriched genes in gene sets with higher expression in
SAT from LBWmen after fasting pointed to 7 enriched transcription fac-
tor bindingmotifs (Table S3, sheet B). In muscle, NRF1 was enriched for
the genes contributing to enrichment of the three gene sets with lower
expression in LBW vs NBWmen after the control study (Table S3, sheet
C), whereas 13 motifs where found for the genes contributing to the
three KEGG pathways downregulated in LBW vs NBWmen after fasting
(Table S3, sheet D). Interestingly, 3 of these transcription factors were
also differentially expressed in muscle from LBW vs NBW men based
on p b 0·05, including NRF1 that showed a higher expression in LBW
men after the control study (p= 0·048), and ELK1 and ELK3 that bothhad higher expression in LBW vs NBW men after fasting (ELK1: p =
0·039; ELK3: p= 0·009; Table S3, sheet C and D).
3.4. Validation of gene expression differences in SAT from LBW vs NBWmen
using data from a different cohort
We have previously shown that a 5-day high-fat overfeeding (HFO)
causes differential expression of N16% of all genes in SAT when combin-
ing data from 24 NBW and 16 LBW men [24]. In the present study, we
used the SAT expression array data from our previous study and per-
formed GSEA analyses to investigate if some of the KEGG gene sets
that were differentially expressed in LBW vs NBW men in the fasting
study were also different between the birth weight groups in the over-
feeding study.
In line with the data presented in Fig. 2, OXPHOS and various other
central metabolic pathways such as TCA cycle, pyruvate metabolism
and biosynthesis of unsaturated fatty acids displayed lower expression
in LBW vs NBW men after a control diet followed by overnight fast in
this independent cohort (Fig. 3A andD; Fig. S1; Table S4, sheet C).More-
over, there was an increased expression of genes in several pathways
related to the immune system in LBW vs NBWmen – several of which
were also upregulated in LBW vs NBWmen after fasting in the present
study (Fig. 2; Fig. S1; Tables S2 and S4). Interestingly, after the 5-day
HFO diet, the expression of genes inmetabolism pathwayswere no lon-
ger significantly different between the birth weight groups (Fig. S1;
Table S4, sheet D). However, LBW men showed an upregulation of the
antigen processing and presentation pathway and a downregulation
of the ribosome pathway compared to NBWmen in SAT after both con-
trol diet and HFO (Fig. S1; Table S4).
Fig. 3. Genes involved in oxidative phosphorylation have lower expression in subcutaneous adipose tissue and skeletal muscle from low vs normal birth weight men after control
conditions and 5 days high-fat overfeeding, but not after 36 h fasting. These plots of log2 delta mRNA values show that OXPHOS genes (n = 142) are lower in SAT (A, B, D) and
skeletal muscle (A, C) from LBW vs NBWmen during control conditions but higher in LBW vs NBWmen after 36 h fasting (A, B, C). HFO, high-fat overfeeding; LBW, low birth weight;
NBW, normal birth weight; OXPHOS, oxidative phosphorylation; SAT, subcutaneous adipose tissue.
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seen in SAT between birth weight groups at control conditions in our
fasting study using data from an independent cohort of LBW and NBW
subjects using similar inclusion criteria.
3.5. Gene expression changes in SAT and muscle after fasting vs control
studies reveal different response in individuals born with LBW compared
with NBW
To investigate if LBW and NBW individuals had a different response
to fasting regarding expression in SAT and muscle, we next compared
the expression levels within each birth weight group after fasting com-
pared to the control study. We only included samples with data from
both time points (fasting and control study), resulting in 7 NBW and
8 LBW men in SAT, and 8 NBW and 8 LBW men in skeletal muscle,
in the paired analyses of the transcriptional response to fasting vs
control.
3.5.1. SAT gene expression
First, we performed a GSEA pathway analysis, here based on data
from paired analyses of all transcripts in the control study compared
with fasting. In SAT fromNBWsubjects, 20 KEGG pathwayswere down-
regulated and none were upregulated after fasting compared with the
control study (Fig. 2; Table S2, sheet E). These were mainly involved
in metabolism, including OXPHOS, carbohydrate, lipid, amino acid and
nucleotide metabolism (Fig. 2; Table S2, sheet E). To visualize how spe-
cific genes in a metabolic gene set were regulated with fasting in the
two groups, we plotted gene expression fold changes (log2) for all
OXPHOS genes in LBW and NBWmen (Fig. 5A). Here, it was clear thatthe same genes were regulated differently in SAT from LBW and NBW
individuals. In SAT from LBWmen, no metabolic pathways were signif-
icantly lower after fasting compared to the control study, and among
the 14 pathways upregulated after fasting, two involved metabolism
(Fig. 2; Table S2, sheet F). Interestingly, while the proteasome pathway
was significantly upregulated in SAT from LBWmenwith fasting, it was
downregulated in SAT from NBW men with fasting (Fig. 2; Table S2,
sheet E and F). Hence, the genome-wide expression changes in response
to fasting were very different in SAT from LBW vs NBW men (Fig. 2;
Fig. 5D).
3.5.2. Muscle gene expression
The gene expression changes seen in response to fasting based on
GSEAweremore similar between LBWandNBWmen in skeletalmuscle
than in SAT. In muscle from NBW individuals, 13 KEGG pathways were
significantly downregulated in response to fasting vs control study and
most of them were related to metabolism (Fig. 4; Table S2, sheet G).
Moreover, ABC transporters (involved inmembrane transport) was up-
regulatedwith fasting in NBWmen (Fig. 4; Table S2, sheet G). Similar to
SAT, OXPHOS was the pathway that was most significantly downregu-
lated with fasting in muscle from NBW men. When plotting the
OXPHOS gene expression fold changes (log2) in LBW and NBW men
(Fig. 5B), it was again clear that the OXPHOS response to fasting was
different in muscle from LBW and NBW men. In muscle from LBW
men, 15 pathways were downregulated after fasting vs control study.
Here, many pathways were involved in cellular processes, but also
metabolism (Fig. 4; Table S2, sheet H). Of note, five pathways were sig-
nificantly downregulated in muscle from both LBW and NBW
subjects after fasting vs control study, e.g. the TCA cycle, GAP junction,
Fig. 4.Gene sets with significantly different mRNA expression in skeletal muscle after 36 h fasting vs control study (horizontally) and in LBW vs NBWmen (vertically). Metabolism KEGG
pathways are coloured by subgroup: Energy (dark blue), Carbohydrate (light blue), Amino acid (purple), Glycan biosynthesis, Cofactors and vitamins and Terpenoids and polyketides
(grey). Human diseases pathways are not included in the figure. *Pathway regulated in the same direction in response to fasting in LBW and NBW men. LBW, low birth weight; NBW,
normal birth weight.
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Table S2, sheet G and H). Taken together, we found different transcrip-
tional responses to fasting for some gene sets in skeletal muscle from
LBW vs NBW men (Fig. 5E), but it was not as pronounced as in SAT
(Fig. 5D).
We proceeded to study expression changes of individual genes. In
both SAT and skeletal muscle we found thousands of nominal associa-
tions (p b 0·05). After correction for multiple testing (FDR b 5%, q b
0·05), in skeletal muscle we found 20 transcripts that changed signifi-
cantly with fasting in LBW men, while 134 transcripts changed with
fasting in NBWmen (Table S5). Four transcripts changed in the same di-
rection (all upregulated) in both groups, representing YPEL1 (LBW fold
change (FC) 1·49, NBW FC 1·65), MAML3 (LBW FC 1·26, NBW FC
1·34), LMTK2 (LBW FC 1·30, NBW FC 1·27) and ZFAND5 (LBW FC
1·46, NBW FC 1·48).
3.6. In contrast to fasting, there are similar expression changes in SAT
in response to 5 days high-fat overfeeding in LBW and NBW men
To investigate if the discrepancy in the SAT gene expression re-
sponse in LBW vs NBW men was specific to fasting or also applied to
other metabolic challenges, we performed new analyses of a SAT
mRNA expression data set from the independent LBW and NBW over-
feeding cohort mentioned above [24]. In this previous study, 16 LBW
men and 24 NBW men were exposed to 5 days of HFO and a control
diet in a randomized order, and mRNA expression was analysed in
SAT biopsies that were excised after overnight (12 h) fasting after
both diets.
In contrast to the results seen after fasting (Fig. 2), based on GSEA
analyses, 5 days HFO induced similar gene expression changes in SATfrom LBW and NBW men (Fig. S1; Table S4, sheet A and B). OXPHOS,
TCA cycle, pyruvate metabolism, biosynthesis of unsaturated fatty
acids and proteasome were among the most significantly upregulated
KEGG gene sets after HFO in both birth weight groups, and among the
24 significantly upregulated KEGG pathways in NBW men, 23 were
also significantly upregulated in the LBW men (Table S4, sheet A and
B). Interestingly, among these 24 pathways upregulated in SAT by
HFO in NBW men, 13 were downregulated in NBW men in response
to fasting (Table S4, sheet B), whereas none of the 40 upregulated path-
ways by HFO in LBWmen were significantly downregulated by fasting.
Only one pathway was significantly downregulated in response to HFO
in the LBW (ribosome) and one in the NBW (ether lipid metabolism)
men, respectively. By plotting fold changes for all OXPHOS genes, it
was clear that these genes were regulated similarly in LBW and NBW
men (Fig. 5C). A highly significant correlation between all transcrip-
tional changes in SAT (R2 = 0.62 for all 28,829 transcripts) to the
HFO challenge, with similar changes in both groups based on a t-test
(p = 0·93), was seen in NBW and LBW men (Fig. 5F), in contrast to
the transcriptional response to 36 h fasting in SAT (R2 = 0·01, t-test:
p=0·6E−14; Fig. 5D). These data demonstrate that the transcriptional
changes in SAT in response to HFO are similar between LBW and NBW
men, while LBW respond transcriptionally differently than NBWmen
to fasting.
3.7. Few DNA methylation differences in genes with different expression in
LBW vs NBW men after control and fasting studies
Epigenetic alterations have been suggested as potentialmechanisms
for how an impaired in utero environment may influence risk of meta-
bolic disease in later life [16,28]. Hence, in the search for molecular
Fig. 5.Men born with low vs normal birth weight have different transcriptional responses to 36 h fasting in adipose tissue and skeletal muscle but similar response to 5 days high-fat
overfeeding in adipose tissue. These plots of log2 delta mRNA values show that OXPHOS genes (A–C; n = 142) and all array transcripts (D–F, n = 28,829) are regulated differently
with fasting in SAT, and partly in muscle, in LBW and NBWmen, and that the mRNA response to overfeeding in SAT is very similar. HFO, high-fat overfeeding; LBW, low birth weight;
NBW, normal birth weight; OXPHOS, oxidative phosphorylation; SAT, subcutaneous adipose tissue.
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fasting between LBW and NBWmen, we investigated the level of DNA
methylation of selected genes and regions based on significant expres-
sion differences.
3.7.1. SAT DNA methylation
First, we extracted a list of genes which expression levels were driv-
ing the significant enrichment for downregulation of the OXPHOS path-
way seen in SAT from LBW vs NBWmen after the control study, which
were also driving the same pathways to be upregulated in LBW vs NBW
men after fasting (Table S2, sheet A and B). We next extracted DNA
methylation data from the sites annotated to the 39 OXPHOS genes
that fulfilled this criterion (735CpG sites). Among these, we foundnom-
inally differential methylation of 27 CpG sites (p b 0·05) in SAT from
LBW vs NBW men after the control study, and of 34 CpG sites after
36 h fasting (Table S6, sheet A). These epigenetic differences were not
significant after correction for multiple testing (q b 0·05) and none of
the CpG sites did overlap, i.e. they were only differentially methylated
(p b 0·05) after the control study or fasting in SAT from LBW vs NBW
men. However, although in different genomic positions, a total of 17
of the selected OXPHOS genes showed differential methylation in both
groups.
Secondly, we extracted methylation data for CpG sites annotated to
the genes driving the KEGG proteasome pathway that was downregu-
lated in SAT from NBW but upregulated in SAT from LBW men after
fasting vs control study (Fig. 2; Table S2, sheet E and F). For the 12
genes driving the enrichment of the proteasome pathway, we found
nominally altered methylation (p b 0·05) after fasting vs the controlstudy of 11 CpG sites in NBW and 7 CpG sites in LBW men (Table S6,
sheet B); none of them did overlap between the groups. Most of these
sites were annotated to PSMD7, SIRT3/PSMD13 and PSME3 (four, three
and three CpG sites, respectively). These results suggest that the impact
of DNA methylation on the differential gene expression in response to
fasting in SAT from LBW vs NBWmen is modest.3.7.2. Skeletal muscle DNA methylation
Finally, we investigated DNAmethylation for CpG sites annotated to
the individual genes in muscle that significantly (q b 0·05) changed ex-
pression after fasting vs control study, from LBWandNBWmen, respec-
tively (Table S5). In the LBW men, 20 individual genes were
differentially expressed in muscle after fasting vs control study with
FDR b 5%. Annotated to 17 of these genes, we found 18 CpG sites with
nominally differential methylation in muscle from LBW men after
fasting vs control study (p b 0·05) (Table S6, sheet C). These include
YPEL1,MAML3, LMTK2 and ZFAND5, which show expression changes in
muscle in both LBW and NBW men after fasting vs control study. In
NBW men, 67 CpG sites annotated to 92 individual genes with altered
muscle expression after fasting vs control study (with q b 0·05) also
displayed nominal differences in methylation with p b 0·05 (Table S6,
sheet B). Here, five CpG sites were annotated to MAML3 and two to
YPEL1.
Although some epigenetic differences were found between the birth
weight groups and in response to fasting, the magnitude and signifi-
cance of these changes were very subtle, unlike the clearly differential
gene expression changes detected in LBW vs NBWmen.
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This study reveals that healthy young men born at term with LBW
have a different transcriptional response to fasting in SAT and, to a
lesser degree, in skeletal muscle, compared to men born with NBW. In-
terestingly, after an isocaloric diet and a regular overnight fast (the con-
trol study), SAT of LBW men showed lower expression of genes
involved in OXPHOS and other pathways for essential carbohydrate
(e.g. glycolysis/gluconeogenesis, TCA cycle, pyruvate metabolism),
amino acid (e.g. beta alanine metabolism, glutathione metabolism, va-
line leucine and isoleucine degradation) and lipid (e.g. biosynthesis of
unsaturated fatty acids) metabolism compared with NBWmen. Impor-
tantly, the lower expression of these and other metabolism pathways
in SAT from LBW vs NBW men was replicated in an independent
study. Also in skeletal muscle, the OXPHOS gene set was significantly
downregulated in LBW vs NBW men after the control study. Notably,
these healthy young LBW men showed a similar phenotype of
OXPHOS gene sets downregulated in both muscle and SAT to subjects
with overt type 2 diabetes [22,25]. Type 2 diabetes is a multifactorial
and polygenic disease where small alterations and/or effect sizes of
many genes contributing to the disease. Indeed, several studies
analysing gene expression in tissues from individuals with type 2 dia-
betes used GSEA to find expression differences in gene sets rather
than focusing on individual genes [22,25,29]. The same applies to the
present study; we found more significant expression differences of
gene sets than of individual genes.
In response to 36 h of fasting, OXPHOS and metabolism gene sets
were downregulated in SAT from NBW men, whereas none of these
gene sets changed significantly in SAT from LBWmen. A similar pattern
was seen in skeletal muscle with the OXPHOS gene pathway downreg-
ulated by fasting in the NBW men only. Consequently, and paradoxi-
cally, the LBW men ended up, after fasting, having higher SAT
expression of essential metabolism gene sets including OXPHOS, glycol-
ysis/gluconeogenesis and beta alanine metabolism compared with the
NBW men. Interestingly, the LBW men in this study had significantly
lower energy expenditure (EE) and fat oxidation (FOX) compared to
the NBW men during fasting [11]. Reduced EE and FOX suggest a
lower capacity for mitochondrial oxidation of fatty acids in LBW men,
which is reflected by our gene expression results of metabolic pathways
in both skeletal muscle and SAT during the control (overnight fasting
only) study.
Previous studies have suggested that the level of energymetabolism
may regulate mRNA turnover/degradation [30]. Hence, the decreased
energy metabolism in LBW men compared with the NBW control
group during fasting, could potentially be associated with relatively de-
creased mRNA turnover/degradation [30]. This is one hypothetical ex-
planation to the otherwise paradoxical finding of reduced in vivo
energy metabolism in the face of increased gene expression levels of
metabolic genes in SAT from LBW subjects during fasting. In further
support of this hypothesis, an association betweenmRNA turnover/deg-
radation and mitochondrial oxidative capacity (mitochondrial content)
has been reported in striatedmuscle fibers [31]. Similarly, another study
showed that decreased expression of a glucose transporter gene was
regulated at themRNAdegradation step in response to decreased glyco-
lytic flux caused by mutations in other genes of the glycolysis pathway
[32]. However, future studies are needed to further dissect this
hypothesis.
Epigenetic programming associated with an adverse foetal develop-
ment could explainwhy LBWmen respond transcriptionally different to
fasting.We studied DNAmethylation differences in genes thatwere dif-
ferentially expressed in both SAT andmuscle, butwe only foundmodest
methylation differences between LBW and NBW groups. Furthermore,
few and only minor changes of DNA methylation induced by fasting
were detected in the CpG sites studied. Nevertheless, among the few
genes showing both differential DNA methylation as well as gene ex-
pression levels in the LBW vs NBW men in this study, some havepreviously been found to be associated with type 2 diabetes including
COX7A1, COX7A2 andUQCRB [22,29,33]. In some of our previous studies,
we found significant DNAmethylation differences in LBW vs NBWmen
[15,24,34]. For example, in SAT biopsies from the validation cohort (HFO
study), we found 53 CpG sites with significant DNA methylation differ-
ences in LBW vs the NBWmen after either control or overfeeding diets,
with absolutemethylation differences of up to 13 percentage points be-
tween groups [24]. Importantly, in another of our previous studies, sub-
stantial epigenetic differences were detected in adipose progenitor cells
from LBW vs NBW men, suggesting that epigenetic differences in
stem cells play a more important role than in mature SAT [34]. This
may explain whywe do not see more impressive epigenetic differences
between birth weight groups in the current work. It should also be
noted that the methylation array only covers ~1.5% of the CpG sites of
the human methylome and that other CpG sites, not analysed here,
may be affected. Interestingly, Kazachenka et al. recently used
whole-genome bisulfite sequencing and RNA sequencing to analyse
the whole methylome and transcriptome in rodents and they found
that retrotransposons with variable DNA methylation only rarely re-
sulted in variable expression of adjacent genes, suggesting that DNA
methylation at repetitive elements most often do not cause phenotypic
effects [35]. In line with this, other epigenetic mechanisms such as
histone modifications and non-coding RNAs might have a larger
contribution to the differences in mRNA levels and responses to
fasting in our study of LBW vs NBW men, which should be further
investigated.
In addition to the differences in OXPHOS and carbohydrate metabo-
lism gene sets during control conditions, LBW subjects also showed
lower SAT expression of gene sets involved in glutathione metabolism,
beta alanine metabolism, and valine, leucine and isoleucine degrada-
tion. These differences were seen consistently in the same overnight
fasted control conditions the validation cohort. Fasting induced a down-
regulation of these pathways in theNBWmenonly. Interestingly, we re-
cently showed that LBW men exhibit disproportionately elevated
plasma alanine, proline, methionine, citrulline as well as total amino
acid levels when exposed to a 5-days high-fat overfeeding challenge
compared with NBW men [36–38]. It may be speculated that reduced
expression of genes involved in amino acid metabolism in adipose tis-
sue, as well as potentially other organs, to some extent may contribute
to elevated plasma amino acid levels in LBW subjects when exposed
to overfeeding. Further studies are needed to confirm or reject this
hypothesis.
We used PSCAN and JASPAR bioinformatical tools to identify
enriched transcription factor motifs in genes that are differentially
expressed in LBW vs NBW men. Interestingly, KLF14 was among the
transcription factors with a significantly enriched binding motif for the
core genes that were driving pathways with significantly lower expres-
sion in SAT from LBW vs NBWmen after control conditions. KLF14 has
been reported to be involved in the development of type 2 diabetes in
humans andmice studies [39,40]. To this end, increased agewas associ-
atedwith increased DNAmethylation of KLF14 in human adipose tissue,
liver, pancreatic islets and blood [12,41,42]. Furthermore, increased
methylation of KLF14 was associated with decreased future risk of
type 2 diabetes and increased insulin secretion [12].
By performing GSEA analyses on SAT gene expression data from
LBW and NBW individuals in one of our previous studies [24], we val-
idated our findings of lower gene expression of gene sets involved in
OXPHOS, TCA cycle and pyruvate metabolism, among others, in LBW
vs NBWmen. Interestingly, we also found that the transcriptional re-
sponse to 5-days high-fat overfeeding (HFO) in SAT was very similar
in both birth weight groups. In fact, of the 24 pathways that were sig-
nificantly upregulated in the LBWmenwith HFO, 23 were also signif-
icantly upregulated in the NBW men, including all 17 metabolism
pathways, and no metabolism pathways were significantly different
between LBW and NBW groups after the 5-day HFO diet. Thus, foetal
growth does not seem to affect the SAT transcriptional response to
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of the pathways that were upregulated by HFO in SAT were also
downregulated by fasting in NBW men, none of the metabolic path-
ways changed in opposite directions with fasting and HFO in LBW
men. Possible explanations to why LBWmen are not downregulating
metabolic pathways during fasting could be that their adipose tissue
has a different degree of inflammation/infiltration of immune cells
after fasting. Immune system pathways including hematopoietic
cell lineage, natural killer mediated cytotoxicity, chemokine signal-
ling and T- and B-cell receptor pathways were upregulated in SAT
from LBWvs NBWmen after fasting, as well as after overnight fasting
in the validation cohort. Infiltrating macrophages have the capability
to secrete inflammatory cytokines and it is speculated that this is a
contributing mechanism for insulin resistance [43]. It is possible
that the expression differences in LBW vs NBWmen predispose to in-
sulin resistance and type 2 diabetes. Indeed, we have previously
shown that the OXPHOS pathway and numerous of the metabolic
pathways downregulated in SAT of LBWmen also are downregulated
in subjects with type 2 diabetes comparedwith non-diabetic controls
[25]. In the same study, we found upregulation of immune system
pathways in SAT of diabetic subjects, in line with what we find al-
ready in young healthy LBW men in this study.
In summary, this study supports the concept of developmental pro-
gramming with early life conditions influencing transcriptional finger-
prints in insulin sensitive tissues. Importantly, transcription of gene
sets involved in metabolism, and energy metabolism in particular, and
to some degree also the epigenetic methylation patterns, are different
in SAT andmuscle from LBW vs NBW young adults already during con-
trol conditions and are downregulated in response to a fasting challenge
only in theNBWmen. These data provide further evidence of an adverse
intrauterine environment to play a key role in the development of met-
abolic disease including type 2 diabetes.
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